Personal Genome Testing Market Report

Global Personal Genome Testing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：159
  • REPORT CODE：GMM770061
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Personal Genome Testing market report explains the definition, types, applications, major countries, and major players of the Personal Genome Testing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • 23andMe Inc

    • Counsyl Inc

    • Color Genomics Inc

    • Quest Diagnostics

    • deCODEme

    • Gene By Gene Ltd

    • Personal Genome Diagnostics Inc

    • Navigenics

    By Type:

    • Targeted Testing

    • Non-Targeted Testing

    • Multi-Targeted Testing

    By End-User:

    • Neurological Disorders

    • Oncology

    • Metabolic Disorders

    • Autoimmune Disorders

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Personal Genome Testing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Personal Genome Testing Outlook to 2028- Original Forecasts

    • 2.2 Personal Genome Testing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Personal Genome Testing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Personal Genome Testing Market- Recent Developments

    • 6.1 Personal Genome Testing Market News and Developments

    • 6.2 Personal Genome Testing Market Deals Landscape

    7 Personal Genome Testing Raw Materials and Cost Structure Analysis

    • 7.1 Personal Genome Testing Key Raw Materials

    • 7.2 Personal Genome Testing Price Trend of Key Raw Materials

    • 7.3 Personal Genome Testing Key Suppliers of Raw Materials

    • 7.4 Personal Genome Testing Market Concentration Rate of Raw Materials

    • 7.5 Personal Genome Testing Cost Structure Analysis

      • 7.5.1 Personal Genome Testing Raw Materials Analysis

      • 7.5.2 Personal Genome Testing Labor Cost Analysis

      • 7.5.3 Personal Genome Testing Manufacturing Expenses Analysis

    8 Global Personal Genome Testing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Personal Genome Testing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Personal Genome Testing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Personal Genome Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Personal Genome Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Targeted Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Targeted Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Multi-Targeted Testing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personal Genome Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Personal Genome Testing Market Analysis and Outlook till 2022

    • 10.1 Global Personal Genome Testing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Personal Genome Testing Consumption (2017-2022)

      • 10.2.2 Canada Personal Genome Testing Consumption (2017-2022)

      • 10.2.3 Mexico Personal Genome Testing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Personal Genome Testing Consumption (2017-2022)

      • 10.3.2 UK Personal Genome Testing Consumption (2017-2022)

      • 10.3.3 Spain Personal Genome Testing Consumption (2017-2022)

      • 10.3.4 Belgium Personal Genome Testing Consumption (2017-2022)

      • 10.3.5 France Personal Genome Testing Consumption (2017-2022)

      • 10.3.6 Italy Personal Genome Testing Consumption (2017-2022)

      • 10.3.7 Denmark Personal Genome Testing Consumption (2017-2022)

      • 10.3.8 Finland Personal Genome Testing Consumption (2017-2022)

      • 10.3.9 Norway Personal Genome Testing Consumption (2017-2022)

      • 10.3.10 Sweden Personal Genome Testing Consumption (2017-2022)

      • 10.3.11 Poland Personal Genome Testing Consumption (2017-2022)

      • 10.3.12 Russia Personal Genome Testing Consumption (2017-2022)

      • 10.3.13 Turkey Personal Genome Testing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Personal Genome Testing Consumption (2017-2022)

      • 10.4.2 Japan Personal Genome Testing Consumption (2017-2022)

      • 10.4.3 India Personal Genome Testing Consumption (2017-2022)

      • 10.4.4 South Korea Personal Genome Testing Consumption (2017-2022)

      • 10.4.5 Pakistan Personal Genome Testing Consumption (2017-2022)

      • 10.4.6 Bangladesh Personal Genome Testing Consumption (2017-2022)

      • 10.4.7 Indonesia Personal Genome Testing Consumption (2017-2022)

      • 10.4.8 Thailand Personal Genome Testing Consumption (2017-2022)

      • 10.4.9 Singapore Personal Genome Testing Consumption (2017-2022)

      • 10.4.10 Malaysia Personal Genome Testing Consumption (2017-2022)

      • 10.4.11 Philippines Personal Genome Testing Consumption (2017-2022)

      • 10.4.12 Vietnam Personal Genome Testing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Personal Genome Testing Consumption (2017-2022)

      • 10.5.2 Colombia Personal Genome Testing Consumption (2017-2022)

      • 10.5.3 Chile Personal Genome Testing Consumption (2017-2022)

      • 10.5.4 Argentina Personal Genome Testing Consumption (2017-2022)

      • 10.5.5 Venezuela Personal Genome Testing Consumption (2017-2022)

      • 10.5.6 Peru Personal Genome Testing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Personal Genome Testing Consumption (2017-2022)

      • 10.5.8 Ecuador Personal Genome Testing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Personal Genome Testing Consumption (2017-2022)

      • 10.6.2 Kuwait Personal Genome Testing Consumption (2017-2022)

      • 10.6.3 Oman Personal Genome Testing Consumption (2017-2022)

      • 10.6.4 Qatar Personal Genome Testing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Personal Genome Testing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Personal Genome Testing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Personal Genome Testing Consumption (2017-2022)

      • 10.7.2 South Africa Personal Genome Testing Consumption (2017-2022)

      • 10.7.3 Egypt Personal Genome Testing Consumption (2017-2022)

      • 10.7.4 Algeria Personal Genome Testing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Personal Genome Testing Consumption (2017-2022)

      • 10.8.2 New Zealand Personal Genome Testing Consumption (2017-2022)

    11 Global Personal Genome Testing Competitive Analysis

    • 11.1 23andMe Inc

      • 11.1.1 23andMe Inc Company Details

      • 11.1.2 23andMe Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 23andMe Inc Personal Genome Testing Main Business and Markets Served

      • 11.1.4 23andMe Inc Personal Genome Testing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Counsyl Inc

      • 11.2.1 Counsyl Inc Company Details

      • 11.2.2 Counsyl Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Counsyl Inc Personal Genome Testing Main Business and Markets Served

      • 11.2.4 Counsyl Inc Personal Genome Testing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Color Genomics Inc

      • 11.3.1 Color Genomics Inc Company Details

      • 11.3.2 Color Genomics Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Color Genomics Inc Personal Genome Testing Main Business and Markets Served

      • 11.3.4 Color Genomics Inc Personal Genome Testing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Quest Diagnostics

      • 11.4.1 Quest Diagnostics Company Details

      • 11.4.2 Quest Diagnostics Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Quest Diagnostics Personal Genome Testing Main Business and Markets Served

      • 11.4.4 Quest Diagnostics Personal Genome Testing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 deCODEme

      • 11.5.1 deCODEme Company Details

      • 11.5.2 deCODEme Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 deCODEme Personal Genome Testing Main Business and Markets Served

      • 11.5.4 deCODEme Personal Genome Testing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Gene By Gene Ltd

      • 11.6.1 Gene By Gene Ltd Company Details

      • 11.6.2 Gene By Gene Ltd Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Gene By Gene Ltd Personal Genome Testing Main Business and Markets Served

      • 11.6.4 Gene By Gene Ltd Personal Genome Testing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Personal Genome Diagnostics Inc

      • 11.7.1 Personal Genome Diagnostics Inc Company Details

      • 11.7.2 Personal Genome Diagnostics Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Personal Genome Diagnostics Inc Personal Genome Testing Main Business and Markets Served

      • 11.7.4 Personal Genome Diagnostics Inc Personal Genome Testing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Navigenics

      • 11.8.1 Navigenics Company Details

      • 11.8.2 Navigenics Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Navigenics Personal Genome Testing Main Business and Markets Served

      • 11.8.4 Navigenics Personal Genome Testing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Personal Genome Testing Market Outlook by Types and Applications to 2028

    • 12.1 Global Personal Genome Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Non-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Multi-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Personal Genome Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Personal Genome Testing Market Analysis and Outlook to 2028

    • 13.1 Global Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.2 UK Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.5 France Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.3 India Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Personal Genome Testing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Personal Genome Testing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Personal Genome Testing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Personal Genome Testing

    • Figure of Personal Genome Testing Picture

    • Table Global Personal Genome Testing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Personal Genome Testing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Multi-Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Personal Genome Testing Consumption by Country (2017-2022)

    • Table North America Personal Genome Testing Consumption by Country (2017-2022)

    • Figure United States Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Canada Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Personal Genome Testing Consumption by Country (2017-2022)

    • Figure Germany Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure UK Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Spain Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure France Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Italy Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Finland Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Norway Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Poland Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Russia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table APAC Personal Genome Testing Consumption by Country (2017-2022)

    • Figure China Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure India Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table South America Personal Genome Testing Consumption by Country (2017-2022)

    • Figure Brazil Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Chile Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Peru Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table GCC Personal Genome Testing Consumption by Country (2017-2022)

    • Figure Bahrain Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Oman Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table Africa Personal Genome Testing Consumption by Country (2017-2022)

    • Figure Nigeria Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table Oceania Personal Genome Testing Consumption by Country (2017-2022)

    • Figure Australia Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table 23andMe Inc Company Details

    • Table 23andMe Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table 23andMe Inc Personal Genome Testing Main Business and Markets Served

    • Table 23andMe Inc Personal Genome Testing Product Portfolio

    • Table Counsyl Inc Company Details

    • Table Counsyl Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Counsyl Inc Personal Genome Testing Main Business and Markets Served

    • Table Counsyl Inc Personal Genome Testing Product Portfolio

    • Table Color Genomics Inc Company Details

    • Table Color Genomics Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Color Genomics Inc Personal Genome Testing Main Business and Markets Served

    • Table Color Genomics Inc Personal Genome Testing Product Portfolio

    • Table Quest Diagnostics Company Details

    • Table Quest Diagnostics Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quest Diagnostics Personal Genome Testing Main Business and Markets Served

    • Table Quest Diagnostics Personal Genome Testing Product Portfolio

    • Table deCODEme Company Details

    • Table deCODEme Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table deCODEme Personal Genome Testing Main Business and Markets Served

    • Table deCODEme Personal Genome Testing Product Portfolio

    • Table Gene By Gene Ltd Company Details

    • Table Gene By Gene Ltd Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gene By Gene Ltd Personal Genome Testing Main Business and Markets Served

    • Table Gene By Gene Ltd Personal Genome Testing Product Portfolio

    • Table Personal Genome Diagnostics Inc Company Details

    • Table Personal Genome Diagnostics Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Personal Genome Diagnostics Inc Personal Genome Testing Main Business and Markets Served

    • Table Personal Genome Diagnostics Inc Personal Genome Testing Product Portfolio

    • Table Navigenics Company Details

    • Table Navigenics Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navigenics Personal Genome Testing Main Business and Markets Served

    • Table Navigenics Personal Genome Testing Product Portfolio

    • Figure Global Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multi-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Table North America Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure Germany Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure China Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure Australia Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US